Lawrence Tim Friedhoff

Title: Innovations of Lawrence Tim Friedhoff

Introduction

Lawrence Tim Friedhoff is an accomplished inventor based in River Vale, NJ (US). He holds a total of five patents, showcasing his significant contributions to the field of pharmaceuticals and neurodegenerative disease treatment. His work primarily focuses on developing compounds that modulate serotonin receptors, which are crucial in addressing hallucinations associated with various conditions.

Latest Patents

Friedhoff's latest patents include innovative compounds such as Diaryl and arylheteroaryl urea derivatives that act as modulators of the 5-HT serotonin receptor. These compounds are particularly useful for the prophylaxis and treatment of hallucinations associated with neurodegenerative diseases, specifically Lewy Body dementia. His inventions aim to provide new therapeutic options for patients suffering from visual hallucinations, enhancing their quality of life.

Career Highlights

Throughout his career, Friedhoff has worked with notable companies in the pharmaceutical industry, including Axovant Sciences GmbH and Eisai Company, Limited. His experience in these organizations has allowed him to contribute to significant advancements in drug development and patient care.

Collaborations

Friedhoff has collaborated with esteemed colleagues such as Shankar Ramaswamy and Yandong Wen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of effective treatments.

Conclusion

Lawrence Tim Friedhoff's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations reflect a commitment to improving the lives of individuals affected by neurodegenerative diseases.